OMNIQ (OMQS) 10-Q 28 Jun 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Jun. 27, 2019
Document and Entity Information
Entity Registrant Name	Quest Solution, Inc.
Entity Central Index Key	0000278165
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Reporting Status Current	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		77,009,547
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 344,000	$ 378,000
Accounts receivable, net	14,205,000	12,262,000
Inventory	1,612,000	1,804,000
Prepaid expenses	489,000	169,000
Other current assets	179,000	78,000
Total current assets	16,829,000	14,690,000
Property and equipment, net of accumulated depreciation of $2,079 and $2,037, respectively	364,000	389,000
Goodwill	13,921,000	13,921,000
Trade name, net of accumulated amortization of $2,672 and $2,585, respectively	1,718,000	1,805,000
Customer relationships, net of accumulated amortization of $5,452 and $5,076, respectively	7,138,000	7,514,000
Other intangibles, net of accumulated amortization of $71 and $33, respectively	1,229,000	1,267,000
Cash, restricted	532,000	532,000
Other assets	243,000	31,000
Total assets	41,974,000	40,148,000
Current liabilities
Accounts payable and accrued liabilities	22,895,000	17,484,000
Accrued interest and accrued liabilities, related party	27,000
Line of credit	797,000	4,534,000
Accrued payroll and sales tax	2,318,000	2,173,000
Notes payable, related parties - current portion	2,072,000	1,891,000
Notes payable - current portion	8,405,000	8,823,000
Other current liabilities	1,195,000	265,000
Total current liabilities	37,709,000	35,170,000
Long term liabilities
Notes payable, related party, less current portion	1,520,000	1,912,000
Accrued interest and accrued liabilities, related party		33,000
Notes payable, less current portion	147,000	130,000
Other long term liabilities	662,000	610,000
Total liabilities	40,038,000	37,930,000
Stockholders' equity
Common stock; $0.001 par value; 200,000,000 shares authorized; 71,425,694 and 36,828,371 shares issued and outstanding, respectively.	71,000	72,000
Common stock; $0.001 par value; 11,084,657 shares to be received		(2,616,000)
Common stock to be repurchased by the Company		(230,000)
Additional paid-in capital	42,291,000	44,814,000
Accumulated (deficit)	(40,432,000)	(39,752,000)
Accumulated other comprehensive loss	1,000	1,000
Total stockholders' equity	1,936,000	2,293,000
Total liabilities and stockholders' equity	41,974,000	40,148,000
Series A Preferred Stock [Member]
Stockholders' equity
Preferred stock, value
Series B Preferred Stock [Member]
Stockholders' equity
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders' equity
Preferred stock, value	$ 5,000	$ 5,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Accumulated depreciation of fixed assets	$ 2,079,000	$ 2,037,000
Accumulated amortization	$ 8,197,503	$ 7,693,971
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	71,426,401	71,931,693
Common stock, shares outstanding	71,426,401	71,931,693
Common stock, shares to be received	11,084,657	11,084,657
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	1	1
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	15,000,000	15,000,000
Preferred stock, shares issued	4,828,530	4,828,530
Preferred stock, shares outstanding	4,828,530	4,828,530
Trade Names [Member]
Accumulated amortization	$ 2,672,154	$ 2,585,404
Customer Relationships [Member]
Accumulated amortization	5,451,622	5,075,999
Other Intangible Assets [Member]
Accumulated amortization	$ 70,727	$ 32,568

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues
Total Revenues	$ 18,620	$ 15,181
Cost of goods sold
Cost of goods sold	14,023	12,014
Total costs of goods sold	14,023	12,014
Gross profit	4,597	3,166
Operating expenses
General and administrative	689	477
Salary and employee benefits	2,855	2,603
Depreciation and amortization	543	437
Professional fees	415	293
Total operating expenses	4,502	3,810
Income (loss) from operations	95	(644)
Other income (expenses):
Interest expense	(684)	(295)
Other (expenses) income	(46)	3
Total other expenses	(730)	(292)
Net loss before Income Taxes	(635)	(936)
Provision for Income Taxes
Current		(13)
Total Provision for Income Taxes		(13)
Net loss attributable to Quest Solution Inc.	(635)	(949)
Less: Preferred stock - Series C dividend	(47)	(48)
Net loss attributable to the common stockholders	$ (682)	$ (997)
Net loss per share - basic	$ (0.01)	$ (0.03)
Net loss per share from continuing operations - basic	$ (0.01)	$ (0.03)
Weighted average number of common shares outstanding - basic	71,681,522	37,125,286

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Shares Repurchased [Member]	Accumulated Deficit [Member]	Other Comprehensive Income (Loss) [Member]	Total
Balance at Dec. 31, 2017	$ 5	$ 37	$ 34,496	$ (230)	$ (35,555)		$ (1,247)
Balance, shares at Dec. 31, 2017	4,829	36,828
ASC 606						1,213	(1,213)
Board Issuances		$ 1	118				119
Board Issuances, shares		1,000
Dividend on Class C Shares						(48)	(48)
ESPP Stock Issuance			4				4
ESPP Stock Issuance, shares		45
Stock-based compensation - options and warrants			352				352
Stock Based Compensation		$ 2	207				209
Stock Based Compensation, shares		1,800
Debt Settlements
Net (loss) income					(949)		(949)
Balance at Mar. 31, 2018	$ 5	$ 40	35,177	(230)	(35,555)	216	(347)
Balance, shares at Mar. 31, 2018	4,829	39,673
Balance at Dec. 31, 2018	$ 5	$ 72	42,198	(230)	(39,752)	1	2,293
Balance, shares at Dec. 31, 2018	4,829	71,932
ASC 606
Dividend on Class C Shares					(47)		(47)
ESPP Stock Issuance			1				1
ESPP Stock Issuance, shares		2
Stock-based compensation - options and warrants			323				323
Stock redemption		$ (1)	(229)	230
Stock redemption, shares		(508)
Accumulated other Comprehensive Loss
Net (loss) income					(633)		(635)
Balance at Mar. 31, 2019	$ 5	$ 71	$ 42,291		$ (40,432)	$ 1	$ 1,936
Balance, shares at Mar. 31, 2019	4,829	71,426

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from continuing operating activities:
Net loss	$ (635,000)	$ (949,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Stock based compensation	323,000	685,000
Topic 606 Cumulative Adjustment		1,213,000
Depreciation and amortization	543,000	487,000
Changes in operating assets and liabilities:
(Increase) / decrease in accounts receivable	(1,941,000)	(3,031,000)
(Increase) / decrease in prepaid	(319,000)	(1,935,000)
(Increase) in inventory	173,000	(1,702,000)
Increase / (decrease) in accounts payable and accrued liabilities	6,214,000	4,987,000
Increase in accrued interest and accrued liabilities, related party		26,000
(Decrease) in deferred revenue, net		(1,213,000)
Increase in accrued payroll and sales taxes payable	144,000	1,259,000
(Increase) / decrease in other assets	(102,000)	98,000
Increase in other liabilities	133,000	35,000
Net cash (used in) provided by operating activities	4,533,000	(40,000)
Cash flows from investing activities:
(Increase) / decrease in restricted cash		303,000
(Increase) / decrease in other assets	(213,000)
Purchase of property and equipment		(54,000)
Net cash provided by investing activities	(213,000)	249,000
Cash flows from financing activities:
Proceeds from ESPP stock issuance	1,000
Proceeds from / (payments on) line of credit	(3,737,000)	1,165,000
Payment on notes/loans payable	(618,000)	(1,154,000)
Net cash provided by (used) in financing activities	(4,354,000)	11,000
Net increase (decrease) in cash	(34,000)	220,000
Cash, beginning of period	378,000	25,000
Cash, end of period	344,000	245,000
Cash paid for interest
Cash paid for taxes
Supplementary for non-cash flow information:
Stock issued for services		209,000
Stock options issued	323,000	473,000
Shares to be repurchased		$ (230,000)

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	NOTE 1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES- BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The interim consolidated financial statements of Quest Solution, Inc. include the combined accounts of Quest Marketing, Inc., an Oregon Corporation, Quest Exchange Ltd., a Canadian based holding company, HTS Image Processing, Inc., a Delaware corporation, HTS (USA), Inc., a Delaware corporation and HTS Image Ltd. (f/k/a Teamtronics Ltd.), an Israeli corporation. On December 31, 2016, the Company acquired one hundred percent (100%) of the shares of Bar Code Specialties, Inc. (“BCS”) and merged BCS into Quest Marketing to form one US legal entity as part of its streamlining efforts. The interim consolidated financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements of the Company for the year ended December 31, 2018 and notes thereto included in the Company’s Form 10-K filed with the SEC on June 5, 2019. The Company follows the same accounting policies in the preparation of interim reports, except for the adoption of ASC Topic 606, Revenue from Contracts with Customers. The Company operates in one segment. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of Quest Solution, Inc. is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements and notes are representations of the Company’s management who is responsible for the integrity and objectivity of the financial statements. These accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements. RECENT ACCOUNTING PRONOUNCEMENTS Adoption of New Accounting Pronouncement in Fiscal 2019 In July 2018, the FASB issued ASU 2018-10 Leases (Topic 842),Codification Improvements Leases (Topic 842), Targeted Improvements . . Leases (Topic 842) In July 2018, the FASB issued ASU 2018-09, Codification Improvements. Compensation-Stock Compensation-Income Taxes, Compensation-Stock Compensation-Income Taxes, In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, Equity - Equity-Based Payments to Non-Employees In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses The Company has evaluated other recent pronouncements and believes that none of them will have a material effect on the Company’s financial statements. GOODWILL AND INTANGIBLE ASSETS Intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from 3 to 11 years. Amortization expense for the period ended March 31, 2019 and December 31, 2018 was $542,309 and $1,784,390, respectively. NET LOSS PER COMMON SHARE Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share.” Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the three months ended March 31, 2019 and 2018 were 71,681,522 and 37,125,286, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive. Dilutive securities are excluded from the computation of diluted net loss per share because such securities have no anti-dilutive impact due to losses reported. The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported, as of March 31,: 2019 2018 Options to purchase common stock 15,841,000 15,081,000 Convertible preferred stock 4,828,530 4,828,530 Warrants to purchase common stock 5,500,000 4,500,000 Common stock subject to repurchase - (507,079 ) Potential shares excluded from diluted net loss per share 26,169,530 19,851,451 FOREIGN CURRENCY TRANSLATION The consolidated financial statements of the Company are presented in U.S. dollars. The functional currency for the Company and each of its subsidiaries (“Quest US entities”), except HTS LTD is U.S. dollars. The functional currency of HTS LTD is Israeli Shekel. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. For Quest US entities, continuing operations are conducted in U.S. dollars. The Company owns a non-operating subsidiary in Canada, from which it has no activity since October 1, 2016. For HTS LTD is an Israeli Company whose continuing operations are conducted in Israeli Shekel. Reclassifications and adjustments

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As of March 31, 2019, the Company had a working capital deficit of $20,880,835 and an accumulated deficit of $40,431,495. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis. Management’s plan to eliminate the going concern situation includes, but is not limited to, the continuation of improving cash flow, maintaining moderate cost reductions (subsequent to aggressive cost reduction actions already taken in 2018 and in the first quarter of 2019), the creation of additional sales and profits across its product lines, and the obtaining of sufficient financing to restructure current debt in a manner more in line with the Company’s improving cash flow and cost reduction successes. The matters that resulted in 2018 having substantial doubt about the Company’s ability to continue as a going concern, have been somewhat mitigated by the successful debt reduction settlements finalized in December of 2017 as detailed in the Company’s Annual Report on Form 10-K filed on June 5, 2019. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Concentrations

Concentrations	3 Months Ended
	Mar. 31, 2019
Risks and Uncertainties [Abstract]
Concentrations	NOTE 3 – CONCENTRATIONS For the three months and year ended March 31, 2019 and December 31, 2018, one customer accounted for 21.4% and 17.0% of the Company’s revenues, respectively.

Business Acquisition

Business Acquisition	3 Months Ended
	Mar. 31, 2019
Business Combinations [Abstract]
Business Acquisition	NOTE 4 – BUSINESS ACQUISITION HTS Image Processing, Inc. acquisition On October 5, 2018 (“Closing Date”), the Company entered into the HTS Purchase Agreement with Walefar and Campbeltown, (Walefar and Campbeltown are collectively referred to as the “Sellers”). Pursuant to the HTS Purchase Agreement, the Company purchased 100% of the capital stock of HTS Image Processing, Inc., and HTS’s wholly owned subsidiaries HTS USA, Inc. and HTS Image Ltd. (f/k/a Teamtronics Ltd.), from the Sellers. Pro forma results of operations The following pro forma results of operations for the three months ended March 31, 2018 have been prepared as though the business acquisition had occurred as of January 1, 2018. This pro forma financial information is not indicative of the results of operations that the Company would have attained had the acquisition occurred at the beginning of the periods presented, nor is the pro forma financial information indicative of the results of operations that may occur in the future: Three Months Ended March 31, 2018 Pro forma sales $ 17,141,884 Pro forma net income (981,186 ) Pro forma basic and diluted earnings per share (0.03 )

Other Liabilities

Other Liabilities	3 Months Ended
	Mar. 31, 2019
Other Liabilities Disclosure [Abstract]
Other Liabilities	NOTE 5 – OTHER LIABILITIES At March 31, 2019 and December 31, 2018, other liabilities consisted of the following: March 31, 2019 December 31, 2018 Lease liability $ 219,507 $ - Other vendor payable 801,000 - Dividend payable 524,806 478,299 Others 310,871 397,122 Total other liabilities 1,856,184 875,421 Less Current Portion (1,194,714 ) (265,178 ) Total long term other liabilities $ 661,470 $ 610,243

Credit Facilities and Line of C

Credit Facilities and Line of Credit	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Credit Facilities and Line of Credit	NOTE 6 – CREDIT FACILITIES AND LINE OF CREDIT On July 1, 2016, the Company entered into a Factoring and Security Agreement (the “FASA”) with Action Capital Corporation (“Action”) to establish a sale of accounts facility, whereby the Company may obtain short-term financing by selling and assigning to Action acceptable accounts receivable. Pursuant to the FASA, the outstanding principal amount of advances made by Action to the Company at any time shall not exceed $5,000,000. Action will reserve and withhold an amount in a reserve account equal to 5% of the face amount of each account purchased under the FASA. The balance outstanding under the Action credit line at March 31, 2019 was $796,952 and $4,533,575 at December 31, 2018, which includes accrued interest. The per annum interest rate with respect to the daily average balance of unpaid advances outstanding under the FASA (computed on a monthly basis) will be equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 2%, plus a monthly fee equal to 0.75% of such average outstanding balance. The Company shall also pay all other costs incurred by Action under the FASA, including all bank fees. The FASA will continue in full force and effect unless terminated by either party upon 30 days’ prior written notice. Performance of the Company’s obligations under the FASA is secured by a security interest in certain collateral of the Company. The FASA includes customary representations and warranties and default provisions for transactions of this type.

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Notes Payable	NOTE 7 - NOTES PAYABLE Notes payable at March 31, 2019 and December 31, 2018, consists of the following: March 31, 2019 December 31, 2018 Supplier Note Payable $ 8,240,465 $ 8,340,465 All Other 311,096 612,980 Total 8,551,564 8,953,445 Less current portion (8,404,560 ) (8,823,151 ) Long Term Notes Payable $ 147,001 $ 130,294 Future maturities of notes payable as of March 31, 2019 are as follows; 2019 $ 8,404,560 2020 16,707 Thereafter 130,294 Total $ 8,551,561 In connection with the BCS’ acquisition, the Company assumed a related party note payable to the former CTO of the RFID division of BCS. The note is payable in equal monthly installments of $4,758 beginning October 31, 2014 and ended October 2018. The loan bears interest at 1.84% and is unsecured and subordinated to the Company’s bank debt. The balance on this loan at March 31, 2019 and March 31, 2018 was $130,294 and $130,294 respectively, of which all of it was classified as long term. In July 2016, the holder of the note signed a subordination agreement with the Supplier of the Secured Promissory Note and Action Capital, whereby the noteholder agrees to subordinate its right to payment of capital and interest until the Supplier with the Secured Promissory Note is reimbursed in full, therefore, the note is classified as long-term. On July 18, 2016, the Company and the supplier entered into that certain Secured Promissory Note, with an effective date of July 1, 2016, in the principal amount of $12,492,137. The USD Note accrues interest at 12% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $250,000 each, with any remaining principal and accrued interest due and payable on December 31, 2016. ● On September 7, 2018, the Company entered into a Sixth Amendment to the secured Promissory Note (the “Sixth Amendment”) extending the maturity date to January 31, 2019. The Sixth Amendment also increases the principal amount to $8,690,464.72, an increase of $6,763,549.41, by rolling the Company’s then existing and outstanding accounts payable into the note by the previously mentioned amount of increase. The Company will continue to make monthly payments in the amount of $300,000 for the first three monthly payments, and also in the amount of $500,000 for the last two monthly payments prior to the notes maturity. ● On April 30, 2019, the Company entered into a Seventh Amendment to the secured Promissory Note (the “Seventh Amendment”) extending the maturity date to July 31, 2019. The Seventh Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest in a minimum principal amount of $350,000 each.

Notes Payable, Related Parties

Notes Payable, Related Parties	3 Months Ended
	Mar. 31, 2019
Notes Payable Related Parties
Notes Payable, Related Parties	NOTE 8 –NOTES PAYABLE, RELATED PARTIES Notes and loans payable, related parties consisted of the following: March 31, 2019 December 31, 2018 Note payable – debt restructure Marin $ 1,060,000 $ 1,160,000 Note payable – debt restructure Thomet 675,000 712,500 Convertible note payable – shareholders 700,000 700,000 Note payable - Certus 986,449 1,059,473 Note payable – debt restructure Zicman 171,000 171,000 Total notes payable, related parties 3,592,449 3,802,973 Less current portion 2,072,449 1,891,000 Long-term portion $ 1,520,000 $ 1,911,973 For the three months ended March 31, 2019 and 2018, the Company recorded interest expense in connection with these notes in the amount of $51,495 and $20,232, respectively. The note payable for acquisition of Quest was issued on January 9, 2014 in conjunction with the acquisition of Quest Marketing, Inc. The initial interest rate was 1.89%, subsequent to December 31, 2015; the interest was increased to 6% and is due in 2018. Principal and interest payments have been postponed. In addition, on June 17, 2016, the Company entered into Promissory Note Conversion Agreement with one of the Noteholders whereby $684,000 of the promissory note was converted into 684,000 shares of Series C Preferred Stock. As part of the transaction, the related debt discount of $171,000 was recorded against Additional paid in capital. As part of the acquisition of Quest Marketing, the Company engaged an independent valuation analysis to do a valuation of the purchase accounting. In July 2016, the holders of the notes signed subordination agreements with the Supplier of the Secured Promissory Note and Action, whereby the noteholders agree to subordinate their rights and payments until the Supplier with the Secured Promissory Note is reimbursed in full. As a result, the balance on this loan and related accrued interest at December 31, 2016 were all classified as long term. The note payable for acquisition of BCS was issued on November 21, 2014 in conjunction with the acquisition of BCS. The current interest is at 1.89% and is due in 2018. This note is convertible into Common Stock at $2.00 per share, subject to board approval such that no debt holder can own more than 5% of the outstanding shares. Principal payments $ and interest payments have been postponed. In July 2016, the holders of the notes signed subordination agreements with the Supplier of the Secured Promissory Note and Action, whereby the noteholder agree to subordinate its right and payment of capital and interest until the Supplier with the Secured Promissory Note is reimbursed in full. As a result, the balance on this loan and related accrued interest at December 31, 2016 were all classified as long term. The Quest preferred stock 6% note payable is in conjunction with the promissory note issued in October 2015 related to the redemption and cancelation of 100% of the issued and outstanding Series A preferred stock as well as 3,400,000 stock options that had been issued to a now former employee. The principal payments have been postponed. In June 2016, the holder of the note granted the Company a forgiveness of debt in the amount of $75,000 which was recorded as an increase in the additional paid in capital because it was a related party transaction. In addition, on June 17, 2016, the Company entered into a Promissory Note Conversion Agreement with the Noteholder whereby $1,800,000 of the promissory note was converted into 1,800,000 shares of Series C Preferred Stock. In July 2016, the holders of the notes signed subordination agreements with the Supplier of the Secured Promissory Note and Action, whereby the noteholder agree to subordinate its right and payment of capital and interest until the Supplier with the Secured Promissory Note is reimbursed in full. As a result, the balance on this loan and related accrued interest at December 31, 2016 were all classified as long term. On February 26, 2018, the Company entered into a lease termination agreement with David and Kathy Marin whereby it cancelled the lease for the premises located at 12272 Monarch St., Garden Grove, California effective as of April 20, 2018. On February 28, 2018, the Company finalized two settlement agreements with David and Kathy Marin (the “Marin Settlement Agreements”) which have an effective date of December 30, 2017. Pursuant to the first Marin Settlement Agreement (the “Marin Settlement Agreement I”), the Company and the Marins agreed to reduce the Company’s purchase price for all of the capital stock of Bar Code Specialties, Inc., which was acquired by the Company from the Marins in November 2014. In the 2014 acquisition, the Company had issued David Marin a promissory note for $11,000,000 of which an aggregate of $10,696,465 (the “Owed Amount”) was outstanding as of February 26, 2018 which includes accrued interest earned but not paid. Pursuant to the Marin Settlement Agreement I, the amount of the indebtedness owed to Marin was reduced by $9,495,465 bringing the total amount owed to $1,201,000. Section 3.1 of the original note was amended to provide that the Company shall pay the Marins 60 monthly payments of $20,000 each commencing the earlier of (i) October 26, 2018 and (ii) the date that the Company’s obligation to Scansource, Inc., currently in the amount of $2,800,000 is satisfied and all amounts currently in default under the credit agreement with Scansource (currently approximately $ 6.0 Million) is reduced to $2.0 million. The Marins agreed to release their security interest against the Company. In connection with the $9,495,465 reduction in the purchase price, the Company issued the Marins 3 year warrants to purchase an aggregate of 3,000,000 shares of Common Stock at an exercise price of $0.20 per share. On February 28, 2018, the Company finalized an additional settlement agreement with the Marins (the “Marin Settlement Agreement II”) whereby the Company settled a promissory note owed to the Marins in the original principal amount of $100,000 which currently had a balance of $111,065 in its entirety in exchange for an aggregate of 85,000 shares of the Company’s Series C Preferred Stock. The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share and automatically converts into Common Stock at $1.00 per share in the event that the Company’s common stock has a closing price of $1.50 per share for 20 consecutive trading days. The preferred stock pays a 6% dividend commencing two years from issuance. During the first two years, the Series C Preferred stock shall neither pay or accrue the dividend. The Company also agreed to transfer title to a vehicle that was being utilized by Mr. Marin to David Marin. In exchange therefor, the $100,000 Note and the accrued interest thereon was cancelled in its entirety. The effective date of the agreement is December 30, 2017. On February 28, 2018, the Company finalized a settlement agreement with Kurt Thomet whereby the Company settled its indebtedness to Mr. Thomet in the current amount of $5,437,136 in full in exchange for 60 monthly payments of $12,500 each commencing the earlier of (i) October 26, 2018 or (ii) the date when the Company’s obligation under its promissory note with Scansource, Inc. currently in the amount of $21,800,000 is satisfied and all amounts currently due under the credit agreement with Scansource (currently approximately $6.0 million) is reduced to $2.0 million. In addition, the Company issued Mr. Thomet an aggregate of 500,000 shares of restricted common stock and 1,000,000 shares of Series C Preferred Stock with the same rights and restrictions as described above in the description of the Marin Settlement II Agreement. The effective date of the agreement is December 30, 2017. On February 28, 2018, the Company finalized a settlement agreement with George Zicman whereby the Company settled its indebtedness to Mr. Zicman in the current amount of $1,304,199 in full in exchange for 60 monthly payments of $3,000 each commencing the earlier of (i) October 26, 2018 or (ii) the date when the Company’s obligation under its promissory note with Scansource, Inc. currently in the amount of $2,800,000 is satisfied and all amounts currently due under the credit agreement with Scansource (currently approximately $6.0 million) is reduced to $2.0 million. In addition, the Company issued Mr. Zicman an aggregate of 100,000 shares of common stock and 600,000 shares of Series C Preferred Stock with the same rights and restrictions as described above in the description of the Marin Settlement Agreement II. The effective date of the agreement is December 30, 2017. Each of the Marins, Thomet and Zicman entered into a voting agreement with the Company whereby they agreed to vote any shares of common stock beneficially owned by them as directed by the Company’s CEO and also agreed to a leakout restriction whereby they each agreed not to sell more than 10% of the common stock beneficially owned during any 30-day period. On June 7, 2018, the Company authorized the issuance of 8,600,000 shares of common stock to Jason Griffith. The issuance was part of a convertible provision in an existing note held by Jason Griffith. With the issuance of stock, the debt of $1,199,400 and all accrued interest was extinguished. On October 5, 2018, the Company entered into a purchase agreement with Walefar Investments, Ltd. (“Walefar”) and Campbeltown Consulting, Inc. (“Campbeltown”) (Walefar and Campbeltown are collectively referred to as the “Sellers”). Pursuant to the agreement, the Company purchased 100% of the capital stock of HTS Image Processing, Inc. (“HTS”) from the Sellers. As consideration, the Company (i) issued to the Sellers 22,452,954 shares of the Company’s common stock, having a value of $5,298,897 based on the average closing price of the common stock for the 20 days’ preceding the agreement (the “Per Share Value”), (ii) cash in the amount of $300,000, and (iii) a 12 month convertible promissory note with a principal amount of $700,000 and an interest rate of six percent (6%) per year. The note also provides the Sellers the right to convert all or any portion of the then outstanding and unpaid principal amount and interest into fully paid and non-assessable shares of the Company’s common stock at a conversion price of $0.236. The agreement constitutes a “related party transaction” because of Company director Shai Lustgarten’s position as Chief Executive Officer of HTS and stock ownership in HTS. Additionally, Campbeltown is a “related party” because Carlos Jaime Nissenson, the beneficial owner of Campbeltown, is a consultant to the Company, a principal stockholder of the Company, and father of Company director Neev Nissenson. Carlos Jaime Nissenson was also a stockholder and director of HTS. Pursuant to the agreement, Shai Lustgarten received 11,226,477 shares of the Company’s common stock and Carlos Jaime Nissenson received 11,226,477 shares of the Company’s common stock. On May 29, 2019, the Company, Campbeltown and Walefar entered into an Amendment to the HTS Purchase Agreement (the “Amendment”), which provided for an adjustment to the number of shares of common stock issued to Walefar and Campbeltown in the acquisition of HTS. Pursuant to the Amendment, Campbeltown and Walefar agreed to return for cancelation 5,542,328 and 5,542,329 shares of common stock, respectively. This Amendment reduced the amount of shares issued in the acquisition to 11,368,297 shares from 22,452,954 shares and the amount of share consideration to approximately $2,682,918 from approximately $5,298,897. This adjustment was made as a result of a correction in the calculation of working capital and other share give back provisions of the HTS Purchase Agreement. On April 4, 2019, the Company entered into a form of Securities Purchase Agreement (the “Securities Purchase Agreement”) with accredited investors (the “Purchasers”). Pursuant to the Securities Purchase Agreement, on April 9, 2019 (the “Closing Date”), the Company sold an aggregate, with the Conversions included, of $5,000,000 of units (the “Units”) resulting in gross proceeds of $5,000,000, before deducting placement agent fees and offering expenses (the “Offering”). The per Unit purchase price was $0.30. Each Unit is comprised of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and a warrant to purchase one share of Common Stock, and, as a result of the Offering, the Company issued 16,666,667 shares of Common Stock (the “Shares”) and warrants (the “Warrants”) to purchase 16,666,667 shares of Common Stock (the “Warrant Shares”) at an exercise price equal to $0.35 per Warrant Share, which Warrants are exercisable for a period of five and one-half years from the issuance date. Both Shai Lustgarten, the Company’s Chief Executive Officer, and Carlos J. Nissensohn, a consultant to and principal stockholder of the Company, participated in the Offering by converting $200,000 each of unpaid principal owed to them from the HTS acquisition (the “Conversions”) by the Company in exchange for Shares and Warrants on the same terms as all other Purchasers. With the Conversions included, the Offering resulted in gross proceeds of $5,000,000. As a result of the Conversions, a principal amount of $150,000 is owed to each Walefar and Campbeltown respectively under the note issued to them as partial consideration in the sale of HTS to the Company on October 5, 2018. The repayment of the notes payable, related parties at March 31, 2019 is as follows: 2019 $ 1,674,400 2020 757,549 2021 426,000 2022 426,000 Thereafter 308,500 Total $ 3,592,449

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Stockholders' Deficit	NOTE 9 – STOCKHOLDERS’ EQUITY PREFERRED STOCK Series A As of March 31, 2019, there were 1,000,000 Series A preferred shares designated and 0 Series A preferred shares outstanding. The board of directors of the Company (the “Board”) had previously set the voting rights for the preferred stock at 1 share of preferred to 250 common shares. Series B As of March 31, 2019, there was 1 preferred share designated and 0 preferred shares outstanding. Series C As of March 31, 2019, there were 15,000,000 Series C preferred share authorized and 4,828,530 Series C preferred share outstanding. It has preferential rights above common shares and the Series B preferred shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum. As part of a debt settlement agreement effective December 30, 2017, 1,685,000 shares were issued with the quarterly dividend at a rate of $0.06 per share per annum were waived for a period of 24 months, with no dividends being accrued or paid. Each Series C preferred share outstanding is convertible into one (1) share of common stock of Quest Solution, Inc. COMMON STOCK On January 10, 2019, the Company issued an aggregate of 623 shares of common stock to four individuals as part of the Company’s Employee Stock Purchase Program for proceeds of $324. On February 19, 2019, the Company issued an aggregate of 457 shares of common stock to certain individuals as part of the Company’s Employee Stock Purchase Program for proceeds of $233. On March 31, 2019, the Company issued an aggregate of 707 shares of common stock to certain individuals as part of the Company’s Employee Stock Purchase Program for proceeds of $252. As of March 31, 2019, the Company had 71,426,401 common shares outstanding. Warrants and Stock Options On March 8, 2018, the Company adopted the Plan as an incentive, to retain in the employ of and as directors, officers, consultants, advisors and employees to the Company. On October 31, 2018, the Board amended the Plan to increase the amount of shares authorized for issuance thereunder from ten million (10,000,000) to sixteen million (16,000,000) shares of the Corporation’s common stock, par value $0.001 (the “Shares”). On January 23, 2019, the Company’s shareholders adopted and ratified the Plan. Warrants March 31, 2019 March 31, 2018 Number of Weighted Number of Weighted Balance, beginning of period 5,500,000 $ 0.23 5,905,000 $ 0.21 Warrants granted - - - - Warrants expired - - (300,000 ) 1.00 Warrants cancelled, forfeited - - - - Warrants exercised - - - - Balance, end of period 5,500,000 $ 0.23 5,605,000 $ 0.21 Exercisable warrants 5,500,000 $ 0.23 4,885,000 $ 0.23 Outstanding warrants as of March 31, 2019 are as follows: Range of Weighted Outstanding Weighted Exercisable Weighted $ 0.11 2.34 1,500,000 $ 0.11 1,500,000 $ 0.11 $ 0.20 1.92 3,000,000 0.20 3,000,000 0.20 $ 0.28 1.25 200,000 $ 0.28 200,000 $ 0.28 $ 0.50 2.50 500,000 0.50 500,000 0.50 $ 0.60 1.51 300,000 $ 0.60 300,000 $ 0.60 $ 0.11 to 0.60 1.92 5,500,000 $ 0.23 5,500,000 $ 0.25 Warrants outstanding at March 31, 2019 and 2018 have the following expiry date and exercise prices: Expiry Date Exercise Prices March 31, 2019 March 31, 2018 October 10, 2020 $ 0.60 300,000 - December 30, 2020 $ 0.20 3,000,000 3,000,000 June 26, 2020 $ 0.28 200,000 - August 2, 2021 $ 0.11 1,500,000 1,500,000 October 10, 2021 $ 0.50 500,000 - 5,500,000 4,500,000 2014 Stock Option Plan On November 17, 2014, the Board adopted a stock option plan (the “2014 Plan”) whereby the Board may grant to directors, officers, employees, or consultants of the Company options to acquire common shares. The Board has the authority to determine the terms, limits, restrictions and conditions of the grant of options, to interpret the plan and make all decisions relating thereto. The 2014 Plan was adopted in order to provide an inducement and serve as a long term incentive program. The maximum number of common shares that may be reserved for issuance was set at ten million (10,000,000). The option exercise price is established by the Board and may not be lower than the market price of the common shares at the time of grant. The options may be exercised during the option period determined by the Board, which may vary, but will not exceed ten years from the date of the grant. There are 10,000,000 of the Company’s common shares which may be issued pursuant to the exercise of share options granted under the 2014 Plan. As at March 31, 2019, the Company had issued options, allowing for the subscription of 20,121,000 shares of its common stock. Stock Options March 31, 2019 March 31, 2018 Number of Weighted Number of Weighted Balance, beginning of period 20,121,000 $ 0.24 9,625,000 $ 0.21 Stock options granted - - 6,800,000 0.12 Stock options expired - - 72,000 0.37 Stock options cancelled, forfeited - - - - Stock options exercised - - - - Balance, end of period 20,121,000 $ 0.24 16,353,000 $ 0.17 Exercisable stock options 15,841,000 $ 0.24 10,167,666 $ 0.20 For the three months ended March 31, 2019, the Company granted a total of 0 stock options. Outstanding stock options as of March 31, 2019 are as follows: Range of Weighted Outstanding Weighted Exercisable Weighted $ 0.075 to 0.09 2.88 2,281,000 $ 0.09 2,281,000 $ 0.08 $ 0.11 2.34 3,500,000 $ 0.11 3,500,000 $ 0.11 $ 0.12 3.93 6,800,000 $ 0.12 5,950,000 $ 0.12 $ 0.22 4.59 2,165,000 $ 0.22 541,250 $ 0.22 $ 0.27 4.67 2,875,000 $ 0.27 1,068,750 $ 0.27 $ 0.50 5.64 2,500,000 $ 0.50 2,500,000 $ 0.50 $ 0.075 to 0.50 3.36 20,121,000 $ 0.24 15,841,000 $ 0.24 Stock options outstanding at March 31, 2019, and 2018 have the following expiration date and exercise prices: Expiration Date Exercise Prices March 31, 2019 March 31, 2018 August 2, 2021 $ 0.11 3,500,000 3,500,000 February 17, 2022 $ 0.075 760,333 760,333 February 17, 2022 $ 0.09 1,520,667 1,520,667 March 5, 2023 $ 0.12 6,800,000 6,800,000 October 31, 2023 $ 0.22 2,165,000 - November 30, 2023 $ 0.27 2,875,000 - November 20, 2024 $ 0.25 2,500,000 - 20,121,000 12,581,000 Stock compensation expense is $322,954 for the three months ended March 31, 2019 and $685,156 for the three months ended March 31, 2018.

Litigation

Litigation	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Litigation	NOTE 10 – LITIGATION Our subsidiary, HTS USA, INC., is currently in litigation with Sagy Amit, a former employee, who claims that he is owed wages and commissions. The case is pending in the Superior Court of California, County of San Diego and discovery has just commenced. The Company intends to vigorously contest the action. The company is not a party to any other pending material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 11 – RELATED PARTY TRANSACTIONS Related party transactions are discussed in Notes 11 and 12.

Leases

Leases	3 Months Ended
	Mar. 31, 2019
Unamortized Share-based Compensation
Leases	NOTE 12 – LEASES The Company accounts for leases in accordance with ASC Topic 842, “Leases,” which requires lessees to recognize a right-of-use asset and lease liability on the balance sheet and expands disclosures about leasing arrangements for both lessees and lessors, among other items, for most lease arrangements. In accordance with the adoption of ASC 842 on January 1, 2019, we recorded operating lease right-of-use (“ROU”) assets, which represent our right to use an underlying asset for the lease term, and operating lease liabilities which represent our obligation to make lease payments. Generally, we enter into operating lease agreements for facilities. Finance lease assets are recorded within property and equipment, net of accumulated depreciation. The amount of operating lease liabilities due within 12 months are recorded in other current liabilities, with the remaining operating lease liabilities recorded as non-current liabilities in our consolidated balance sheet based on their contractual due dates. Finance lease liabilities are classified according to contractual due dates. The operating lease ROU assets and liabilities are recognized as of the lease commencement date at the present value of the lease payments over the lease term. Most of our leases do not provide an implicit rate that can readily be determined. Therefore, we use a discount rate based on our incremental borrowing rate which was between 13.16% and 15.06% for all operating leases. Our operating lease agreements may include options to extend the lease term or terminate it early. We have included options to extend in the operating lease ROU assets and liabilities when we are reasonably certain that we will exercise such options. The weighted average remaining lease terms and discount rates for our operating leases were approximately 2.7 years and 14.6% at March 31, 2019. We did not have finance leases at March 31, 2019. Operating lease expense is recognized as rent expense on a straight-line basis over the lease term. We evaluate ROU assets for impairment consistent with our property and equipment policy disclosure included in our 2018 Form 10-K. As of March 31, 2019, operating lease ROU assets were $214,611 and operating lease liabilities were $219,507, of which $121,405 were classified as noncurrent. Future minimum lease commitments at March 31, 2019 were as follows: Year ending December 31, Operating Leases 2019 (excluding the three months ended March 31, 2019) $ 94,971 2020 81,919 2021 36,365 2022 and thereafter 53,200 Total lease payments 266,456 Less imputed interest (46,949 ) Total $ 219,507 Supplemental cash flow information related to leases was as follows: Three Months Ended Cash paid for amounts included in the measurement of lease liabilities: Cash flows from operating activities - operating leases $ 19,916 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 17,066

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	NOTE 13 – SUBSEQUENT EVENTS On May 29, 2019, the Company, Campbeltown and Walefar entered into an Amendment to the HTS Purchase Agreement (the “Amendment”), which provided for an adjustment to the number of shares of common stock issued to Walefar and Campbeltown in the acquisition of HTS. Pursuant to the Amendment, Campbeltown and Walefar agreed to return for cancelation 5,542,328 and 5,542,329 shares of common stock, respectively. This Amendment reduced the amount of shares issued in the acquisition to 11,368,297 shares from 22,452,954 shares and the amount of share consideration to approximately $2,682,918 from approximately $5,298,897. This adjustment was made as a result of a correction in the calculation of working capital and other share give back provisions of the HTS Purchase Agreement. On April 4, 2019, the Company entered into a form of Securities Purchase Agreement (the “Securities Purchase Agreement”) with accredited investors (the “Purchasers”). Pursuant to the Securities Purchase Agreement, on April 9, 2019 (the “Closing Date”), the Company sold an aggregate, with the Conversions included, of $5,000,000 of units (the “Units”) resulting in gross proceeds of $5,000,000, before deducting placement agent fees and offering expenses (the “Offering”). The per Unit purchase price was $0.30. Each Unit is comprised of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and a warrant to purchase one share of Common Stock, and, as a result of the Offering, the Company issued 16,666,667 shares of Common Stock (the “Shares”) and warrants (the “Warrants”) to purchase 16,666,667 shares of Common Stock (the “Warrant Shares”) at an exercise price equal to $0.35 per Warrant Share, which Warrants are exercisable for a period of five and one-half years from the issuance date. Both Shai Lustgarten, the Company’s Chief Executive Officer, and Carlos J. Nissensohn, a consultant to and principal stockholder of the Company, participated in the Offering by converting $200,000 each of unpaid principal owed to them from the HTS acquisition (the “Conversions”) by the Company in exchange for Shares and Warrants on the same terms as all other Purchasers. With the Conversions included, the Offering resulted in gross proceeds of $5,000,000. As a result of the Conversions, a principal amount of $150,000 is owed to each Walefar and Campbeltown respectively under the note issued to them as partial consideration in the sale of HTS to the Company on October 5, 2018.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS Adoption of New Accounting Pronouncement in Fiscal 2019 In July 2018, the FASB issued ASU 2018-10 Leases (Topic 842),Codification Improvements Leases (Topic 842), Targeted Improvements . . Leases (Topic 842) In July 2018, the FASB issued ASU 2018-09, Codification Improvements. Compensation-Stock Compensation-Income Taxes, Compensation-Stock Compensation-Income Taxes, In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, Equity - Equity-Based Payments to Non-Employees In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses The Company has evaluated other recent pronouncements and believes that none of them will have a material effect on the Company’s financial statements.
Goodwill and Intangible Assets	GOODWILL AND INTANGIBLE ASSETS Intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from 3 to 11 years. Amortization expense for the period ended March 31, 2019 and December 31, 2018 was $542,309 and $1,784,390, respectively.
Net Loss Per Common Share	NET LOSS PER COMMON SHARE Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share.” Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the three months ended March 31, 2019 and 2018 were 71,681,522 and 37,125,286, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive. Dilutive securities are excluded from the computation of diluted net loss per share because such securities have no anti-dilutive impact due to losses reported. The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported, as of March 31,: 2019 2018 Options to purchase common stock 15,841,000 15,081,000 Convertible preferred stock 4,828,530 4,828,530 Warrants to purchase common stock 5,500,000 4,500,000 Common stock subject to repurchase - (507,079 ) Potential shares excluded from diluted net loss per share 26,169,530 19,851,451
Foreign Currency Translation	FOREIGN CURRENCY TRANSLATION The consolidated financial statements of the Company are presented in U.S. dollars. The functional currency for the Company and each of its subsidiaries (“Quest US entities”), except HTS LTD is U.S. dollars. The functional currency of HTS LTD is Israeli Shekel. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. For Quest US entities, continuing operations are conducted in U.S. dollars. The Company owns a non-operating subsidiary in Canada, from which it has no activity since October 1, 2016. For HTS LTD is an Israeli Company whose continuing operations are conducted in Israeli Shekel.
Reclassifications and Adjustments	Reclassifications and adjustments

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Anti Dilutive Securities Excludes from Computation	The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported, as of March 31,: 2019 2018 Options to purchase common stock 15,841,000 15,081,000 Convertible preferred stock 4,828,530 4,828,530 Warrants to purchase common stock 5,500,000 4,500,000 Common stock subject to repurchase - (507,079 ) Potential shares excluded from diluted net loss per share 26,169,530 19,851,451

Business Acquisition (Tables)

Business Acquisition (Tables)	3 Months Ended
	Mar. 31, 2019
Business Combinations [Abstract]
Schedule of Proforma Results of Operations	This pro forma financial information is not indicative of the results of operations that the Company would have attained had the acquisition occurred at the beginning of the periods presented, nor is the pro forma financial information indicative of the results of operations that may occur in the future: Three Months Ended March 31, 2018 Pro forma sales $ 17,141,884 Pro forma net income (981,186 ) Pro forma basic and diluted earnings per share (0.03 )

Other Liabilities (Tables)

Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2019
Other Liabilities Disclosure [Abstract]
Schedule of Other Liabilities	At March 31, 2019 and December 31, 2018, other liabilities consisted of the following: March 31, 2019 December 31, 2018 Lease liability $ 219,507 $ - Other vendor payable 801,000 - Dividend payable 524,806 478,299 Others 310,871 397,122 Total other liabilities 1,856,184 875,421 Less Current Portion (1,194,714 ) (265,178 ) Total long term other liabilities $ 661,470 $ 610,243

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Schedule of Notes Payable	Notes payable at March 31, 2019 and December 31, 2018, consists of the following: March 31, 2019 December 31, 2018 Supplier Note Payable $ 8,240,465 $ 8,340,465 All Other 311,096 612,980 Total 8,551,564 8,953,445 Less current portion (8,404,560 ) (8,823,151 ) Long Term Notes Payable $ 147,001 $ 130,294
Schedule of Future Maturities of Note Payable	Future maturities of notes payable as of March 31, 2019 are as follows; 2019 $ 8,404,560 2020 16,707 Thereafter 130,294 Total $ 8,551,561

Notes Payable, Related Parties

Notes Payable, Related Parties (Tables)	3 Months Ended
	Mar. 31, 2019
Unamortized Share-based Compensation
Schedule of Notes Payable, Related Parties	Notes and loans payable, related parties consisted of the following: March 31, 2019 December 31, 2018 Note payable – debt restructure Marin $ 1,060,000 $ 1,160,000 Note payable – debt restructure Thomet 675,000 712,500 Convertible note payable – shareholders 700,000 700,000 Note payable - Certus 986,449 1,059,473 Note payable – debt restructure Zicman 171,000 171,000 Total notes payable, related parties 3,592,449 3,802,973 Less current portion 2,072,449 1,891,000 Long-term portion $ 1,520,000 $ 1,911,973
Schedule of Future Maturities of Notes Payable, Related Parties	The repayment of the notes payable, related parties at March 31, 2019 is as follows: 2019 $ 1,674,400 2020 757,549 2021 426,000 2022 426,000 Thereafter 308,500 Total $ 3,592,449

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Schedule of Stock Options Warrants	The following table summarizes information about warrants granted during the three month periods ended March 31, 2019 and 2018: March 31, 2019 March 31, 2018 Number of Weighted Number of Weighted Balance, beginning of period 5,500,000 $ 0.23 5,905,000 $ 0.21 Warrants granted - - - - Warrants expired - - (300,000 ) 1.00 Warrants cancelled, forfeited - - - - Warrants exercised - - - - Balance, end of period 5,500,000 $ 0.23 5,605,000 $ 0.21 Exercisable warrants 5,500,000 $ 0.23 4,885,000 $ 0.23
Schedule of Outstanding Warrants	Outstanding warrants as of March 31, 2019 are as follows: Range of Weighted Outstanding Weighted Exercisable Weighted $ 0.11 2.34 1,500,000 $ 0.11 1,500,000 $ 0.11 $ 0.20 1.92 3,000,000 0.20 3,000,000 0.20 $ 0.28 1.25 200,000 $ 0.28 200,000 $ 0.28 $ 0.50 2.50 500,000 0.50 500,000 0.50 $ 0.60 1.51 300,000 $ 0.60 300,000 $ 0.60 $ 0.11 to 0.60 1.92 5,500,000 $ 0.23 5,500,000 $ 0.25
Schedule of Warrants Outstanding, Expiry Date and Exercise Prices	Warrants outstanding at March 31, 2019 and 2018 have the following expiry date and exercise prices: Expiry Date Exercise Prices March 31, 2019 March 31, 2018 October 10, 2020 $ 0.60 300,000 - December 30, 2020 $ 0.20 3,000,000 3,000,000 June 26, 2020 $ 0.28 200,000 - August 2, 2021 $ 0.11 1,500,000 1,500,000 October 10, 2021 $ 0.50 500,000 - 5,500,000 4,500,000
Schedule of Stock Options Granted	The following table summarizes information about stock options granted during the three months ended March 31, 2019 and 2018: March 31, 2019 March 31, 2018 Number of Weighted Number of Weighted Balance, beginning of period 20,121,000 $ 0.24 9,625,000 $ 0.21 Stock options granted - - 6,800,000 0.12 Stock options expired - - 72,000 0.37 Stock options cancelled, forfeited - - - - Stock options exercised - - - - Balance, end of period 20,121,000 $ 0.24 16,353,000 $ 0.17 Exercisable stock options 15,841,000 $ 0.24 10,167,666 $ 0.20
Schedule of Outstanding Stock Options	Outstanding stock options as of March 31, 2019 are as follows: Range of Weighted Outstanding Weighted Exercisable Weighted $ 0.075 to 0.09 2.88 2,281,000 $ 0.09 2,281,000 $ 0.08 $ 0.11 2.34 3,500,000 $ 0.11 3,500,000 $ 0.11 $ 0.12 3.93 6,800,000 $ 0.12 5,950,000 $ 0.12 $ 0.22 4.59 2,165,000 $ 0.22 541,250 $ 0.22 $ 0.27 4.67 2,875,000 $ 0.27 1,068,750 $ 0.27 $ 0.50 5.64 2,500,000 $ 0.50 2,500,000 $ 0.50 $ 0.075 to 0.50 3.36 20,121,000 $ 0.24 15,841,000 $ 0.24
Schedule of Stock Options, Expiry Date and Exercise Prices	Stock options outstanding at March 31, 2019, and 2018 have the following expiration date and exercise prices: Expiration Date Exercise Prices March 31, 2019 March 31, 2018 August 2, 2021 $ 0.11 3,500,000 3,500,000 February 17, 2022 $ 0.075 760,333 760,333 February 17, 2022 $ 0.09 1,520,667 1,520,667 March 5, 2023 $ 0.12 6,800,000 6,800,000 October 31, 2023 $ 0.22 2,165,000 - November 30, 2023 $ 0.27 2,875,000 - November 20, 2024 $ 0.25 2,500,000 - 20,121,000 12,581,000

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2019
Unamortized Share-based Compensation
Schedule of Future Minimum Lease Commitments	Future minimum lease commitments at March 31, 2019 were as follows: Year ending December 31, Operating Leases 2019 (excluding the three months ended March 31, 2019) $ 94,971 2020 81,919 2021 36,365 2022 and thereafter 53,200 Total lease payments 266,456 Less imputed interest (46,949 ) Total $ 219,507
Schedule of Supplemental Cash Flow Information	Supplemental cash flow information related to leases was as follows: Three Months Ended Cash paid for amounts included in the measurement of lease liabilities: Cash flows from operating activities - operating leases $ 19,916 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 17,066

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Jan. 02, 2019	Dec. 31, 2016
Right-of-use assets	$ 214,611			$ 237,731
Lease liabilities	219,507			$ 237,731
Amortization expense	$ 542,309		$ 1,784,390
Weighted average number of common shares outstanding	71,681,522	37,125,286
Minimum [Member]
Finite-lived intangible asset, useful life	3 years
Maximum [Member]
Finite-lived intangible asset, useful life	11 years
Bar Code Specialties Inc. [Member]
Percentage of shares acquired					100.00%

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Potential shares excluded from diluted net loss per share	26,169,530	19,851,451
Options to Purchase Common Stock [Member]
Potential shares excluded from diluted net loss per share	15,841,000	15,081,000
Convertible Preferred Stock [Member]
Potential shares excluded from diluted net loss per share	4,828,530	4,828,530
Warrants to Purchase Common Stock [Member]
Potential shares excluded from diluted net loss per share	5,500,000	4,500,000
Common Stock Subject to Repurchase [Member]
Potential shares excluded from diluted net loss per share		(507,079)

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ 20,880,835
Accumulated deficit	$ (40,432,000)	$ (39,752,000)

Concentrations (Details Narrati

Concentrations (Details Narrative)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Revenue [Member] | One Customer [Member]
Percentage of concentration risk	21.40%	17.00%

Business Acquisition (Details N

Business Acquisition (Details Narrative)	Mar. 31, 2019
HTS Purchase Agreement [Member]
Percentage of voting interest acquired	100.00%

Business Acquisition - Schedule

Business Acquisition - Schedule of Proforma Results of Operations (Details)	3 Months Ended
	Mar. 31, 2019USD ($)$ / shares
Business Combinations [Abstract]
Pro forma sales	$ 17,141,884
Pro forma net income	$ (981,186)
Pro forma basic and diluted earnings per share | $ / shares	$ (0.03)

Other Liabilities - Schedule of

Other Liabilities - Schedule of Other Liabilities (Details) - USD ($)	Mar. 31, 2019	Jan. 02, 2019	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Lease liability	$ 219,507	$ 237,731
Other vendor payable	801,000
Dividend payable	524,806		478,299
Others	310,871		397,122
Total other liabilities	1,856,184		875,421
Less Current Portion	(1,195,000)		(265,000)
Total long term other liabilities	$ 662,000		$ 610,000

Credit Facilities and Line of_2

Credit Facilities and Line of Credit (Details Narrative) - USD ($)	Jul. 01, 2016	Mar. 31, 2019	Dec. 31, 2018
Line of credit, balance		$ 797,000	$ 4,534,000
Factoring and Security Agreement [Member] | Action Capital Corporation [Member]
Line of credit maximum borrowing capacity	$ 5,000,000
Percentage of reserve account	5.00%
Percentage of average outstanding balance	0.75%
Factoring and Security Agreement [Member] | Action Capital Corporation [Member] | Prime Rate [Member]
Percentage of average outstanding balance	2.00%

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Sep. 07, 2018	Jul. 18, 2016	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Nov. 21, 2014
Notes payable			$ 8,551,564	$ 8,953,445
Secured Promissory Note [Member]
Debt instruments periodic payment		$ 250,000
Debt instruments interest rate		12.00%
Debt instrument face amount		$ 12,492,137
Debt instrument due date		Dec. 31, 2016
Sixth Amendment Agreement [Member] | Secured Promissory Note [Member]
Debt instrument face amount	$ 8,690,465
Debt instrument due date	Jan. 31, 2019
Debt instrument, increase, accrued interest	$ 6,763,549
Seventh Amendment Agreement [Member] | April 30, 2019 [Member] | Secured Promissory Note [Member]
Debt instrument due date			Jul. 31, 2019
Debt instrument, increase, accrued interest			$ 350,000
BCS Acquisition [Member]
Debt instruments periodic payment			$ 4,758
Debt instruments interest rate			1.84%			1.89%
BCS Acquisition [Member] | Debt [Member]
Notes payable			$ 130,294		$ 130,294
First Three Monthly Payments [Member] | Sixth Amendment Agreement [Member] | Secured Promissory Note [Member]
Debt instrument periodic principal amount	300,000
Last Two Monthly Payments [Member] | Sixth Amendment Agreement [Member] | Secured Promissory Note [Member]
Debt instrument periodic principal amount	$ 500,000

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Total notes payable	$ 8,551,564	$ 8,953,445
Less: current portion	(8,405,000)	(8,823,000)
Long Term Notes Payable	147,000	130,000
Supplier Note Payable [Member]
Total notes payable	8,240,465	8,340,465
All Other [Member]
Total notes payable	$ 311,096	$ 612,980

Notes Payable - Schedule of Fut

Notes Payable - Schedule of Future Maturities of Note Payable (Details) - Notes Payable [Member]	Mar. 31, 2019USD ($)
2019	$ 8,404,560
2020	16,707
Thereafter	130,294
Total	$ 8,551,561

Notes Payable, Related Partie_2

Notes Payable, Related Parties (Details Narrative)

Oct. 05, 2018USD ($)ft²$ / sharesshares

Jun. 07, 2018USD ($)shares

Feb. 28, 2018USD ($)ft²$ / sharesshares

Feb. 28, 2018USD ($)$ / shares

Jun. 17, 2016USD ($)shares

Nov. 21, 2014$ / shares

Jan. 09, 2014

Jun. 30, 2016USD ($)

Oct. 31, 2015shares

Mar. 31, 2019USD ($)$ / sharesshares

Mar. 31, 2018USD ($)shares

Dec. 31, 2014USD ($)ft²$ / sharesshares

Dec. 31, 2018$ / sharesshares

Interest expense

$ 51,495

$ 20,232

Number of common stock value issued

$ 119,000

Common stock, shares authorized | shares

200,000,000

200,000,000

Common stock, par value | $ / shares

$ 0.001

$ 0.001

Common Stock [Member]

Number of shares issued for common stock | shares

1,000

Number of common stock value issued

$ 1,000

Campbeltown Consulting, Inc [Member]

Debt instrument conversion of shares amount

$ 150,000

Walefar Investments, Ltd [Member]

Debt instrument conversion of shares amount

$ 150,000

Series C Preferred Stock [Member]

Number of shares issued for common stock | shares

Number of common stock value issued

Series A Preferred Stock [Member]

Debt instruments interest rate

6.00%

Percentage of redemption and cancelation

100.00%

Number of option issued | shares

3,400,000

Jason Griffith [Member]

Common stock, shares authorized | shares

8,600,000

Extinguishment of debt

$ 1,199,400

Shai Lustgarten [Member] | Common Stock [Member]

Number of shares issued for common stock | shares

11,226,477

Carlos Jaime Nissenson [Member] | Common Stock [Member]

Number of shares issued for common stock | shares

11,226,477

Promissory Note Conversion Agreement [Member] | Noteholders [Member]

Forgiveness of debt

$ 75,000

Promissory Note Conversion Agreement [Member] | Noteholders [Member] | Series C Preferred Stock [Member]

Debt instrument conversion of shares amount

$ 1,800,000

Debt instrument conversion of shares | shares

1,800,000

Marin Settlement Agreement I [Member] | David Marin [Member]

Forgiveness of debt

$ 9,495,465

Debt instrument face amount

11,000,000

Debt owed amount

$ 1,201,000

Date of agreement

Feb. 28, 2018

Debt instrument description

(i) October 26, 2018 and (ii) the date that the Company's obligation to Scansource, Inc., currently in the amount of $2,800,000 is satisfied and all amounts currently in default under the credit agreement with Scansource (currently approximately $ 6.0 Million) is reduced to $2.0 million.

Section 3.1 of the original note was amended to provide that the Company shall pay the Marins 60 monthly payments of $20,000 each commencing the earlier of (i) October 26, 2018 and (ii) the date that the Company's obligation to Scansource, Inc., currently in the amount of $1,800,000 is satisfied and all amounts currently in default under the credit agreement with Scansource (currently approximately $ 6.0 Million) is reduced to $2.0 million.

Number of monthly installments | ft²

60

Debt monthly payment

$ 20,000

Warrants term

3 years

Number of warrants to purchase common stock | shares

3,000,000

Warrant exercise price per share | $ / shares

$ 0.20

Marin Settlement Agreement I [Member] | David Marin [Member] | Scansource, Inc [Member]

Debt instrument face amount

$ 6,000,000

$ 6,000,000

Debt default, amount

2,800,000

2,800,000

Reduction in debt default amount

2,000,000

Marin Settlement Agreement I [Member] | David Marin [Member] | Owed Amount [Member]

Debt owed amount

$ 10,696,465

Marin Settlement Agreement II [Member] | David Marin [Member]

Debt instrument conversion of shares amount

111,065

Debt instrument face amount

$ 100,000

$ 100,000

Marin Settlement Agreement II [Member] | David Marin [Member] | Series C Preferred Stock [Member]

Debt instrument conversion of shares | shares

85,000

Debt convertible price per share | $ / shares

$ 1

$ 1

Shares issued, price per share | $ / shares

1

$ 1

Debt instrument, convertible, stock price | $ / shares

$ 1.50

Debt instrument, convertible, consecutive trading days | ft²

20

Preferred stock, dividend rate, percentage

6.00%

Value of note and accrued interest cancelled

$ 100,000

Settlement Agreement [Member] | Kurt Thomet [Member]

Date of agreement

Feb. 22, 2018

Debt instrument description

(i) October 26, 2018 or (ii) the date when the Company's obligation under its promissory note with Scansource, Inc. currently in the amount of $21,800,000 is satisfied and all amounts currently due under the credit agreement with Scansource (currently approximately $6.0 million) is reduced to $2.0 million.

Number of monthly installments | ft²

60

Debt monthly payment

$ 12,500

Aggregate indebtness

$ 5,437,136

$ 5,437,136

Number of restricted common stock shares | shares

500,000

Settlement Agreement [Member] | Kurt Thomet [Member] | Scansource, Inc [Member]

Debt instrument face amount

$ 6,000,000

6,000,000

Debt default, amount

$ 21,800,000

21,800,000

Reduction in debt default amount

2,000,000

Settlement Agreement [Member] | Kurt Thomet [Member] | Series C Preferred Stock [Member]

Number of shares issued for common stock | shares

1,000,000

Settlement Agreement [Member] | George Zicman [Member]

Date of agreement

Feb. 22, 2018

Debt instrument description

(i) October 26, 2018 or (ii) the date when the Company's obligation under its promissory note with Scansource, Inc. currently in the amount of $2,800,000 is satisfied and all amounts currently due under the credit agreement with Scansource (currently approximately $6.0 million) is reduced to $2.0 million.

Number of monthly installments | ft²

60

Debt monthly payment

$ 3,000

Aggregate indebtness

$ 1,304,199

1,304,199

Number of shares issued for common stock | shares

100,000

Settlement Agreement [Member] | George Zicman [Member] | Scansource, Inc [Member]

Debt instrument face amount

$ 6,000,000

6,000,000

Debt default, amount

2,800,000

$ 2,800,000

Reduction in debt default amount

$ 2,000,000

Settlement Agreement [Member] | Goerge Zicman [Member] | Series C Preferred Stock [Member]

Number of shares issued for common stock | shares

600,000

Voting Agreement [Member] | Marins, Kurt Thomet And Goerge Zicman [Member]

Beneficiary percentage of common stock

10.00%

Purchase Agreement [Member] | Common Stock [Member]

Debt instruments interest rate

6.00%

Debt instrument description

The common stock for the 20 days' preceding the agreement (the "Per Share Value"), (ii) cash in the amount of $300,000, and (iii) a 12 month convertible promissory note with a principal amount of $700,000 and an interest rate of six percent (6%) per year.

Debt instrument, convertible, consecutive trading days | ft²

20

Number of shares issued for common stock | shares

22,452,954

Number of common stock value issued

$ 5,298,897

Cash amount

$ 300,000

Purchase Agreement [Member] | HTS Image Processing, Inc [Member]

Purchased percentage of capital stock

100.00%

Purchase Agreement [Member] | Convertible Promissory Note [Member]

Debt convertible price per share | $ / shares

$ 0.236

Debt instrument face amount

$ 700,000

HTS Purchase Agreement [Member] | May 29, 2019 [Member]

Number of shares issued for acquisition, shares | shares

22,452,954

Number of acquisition shares reduced | shares

11,368,297

Number of shares issued for acquisition

$ 5,298,897

Number of shares issued for acquisition reduced

$ 2,682,918

HTS Purchase Agreement [Member] | Campbeltown Consulting, Inc [Member] | May 29, 2019 [Member]

Number of shares in cancelation | shares

5,542,328

HTS Purchase Agreement [Member] | Walefar Investments, Ltd [Member] | May 29, 2019 [Member]

Number of shares in cancelation | shares

5,542,329

Securities Purchase Agreement [Member] | April 4, 2019 [Member]

Debt instrument conversion of shares amount

$ 200,000

Debt instrument description

Each Unit is comprised of one share of the Company's common stock, $0.001 par value per share (the "Common Stock"), and a warrant to purchase one share of Common Stock, and, as a result of the Offering, the Company issued 16,666,667 shares of Common Stock (the "Shares") and warrants (the "Warrants") to purchase 16,666,667 shares of Common Stock (the "Warrant Shares") at an exercise price equal to $0.35 per Warrant Share, which Warrants are exercisable for a period of five and one-half years from the issuance date.

Number of warrants to purchase common stock | shares

16,666,667

Warrant exercise price per share | $ / shares

$ 0.35

Number of shares issued for common stock | shares

16,666,667

Consideration of share amount

$ 5,000,000

Common stock, par value | $ / shares

$ 0.001

Gross proceeds from offering

$ 5,000,000

Purchase price per share | $ / shares

$ 0.30

Quest Marketing, Inc [Member]

Debt instruments interest rate

1.89%

Debt instruments interest increase

6.00%

Debt due date description

2018

Quest Marketing, Inc [Member] | Promissory Note Conversion Agreement [Member] | Noteholders [Member] | Series C Preferred Stock [Member]

Debt instrument conversion of shares amount

$ 684,000

Debt instrument conversion of shares | shares

684,000

Debt discount

$ 171,000

BCS Acquisition [Member]

Debt instruments interest rate

1.89%

1.84%

Debt due date description

2018

Debt convertible price per share | $ / shares

$ 2

Percentage of outstanding shares

5.00%

Notes Payable, Related Partie_3

Notes Payable, Related Parties - Schedule of Notes Payable, Related Parties (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Total notes payable	$ 3,592,449	$ 3,802,973
Less current portion	2,072,000	1,891,000
Long-term portion	1,520,000	1,912,000
Note Payable - Debt Restructure Marin [Member]
Total notes payable	1,060,000	1,160,000
Note Payable - Debt Restructure Thomet [Member]
Total notes payable	675,000	712,500
Convertible Note Payable - Shareholders [Member]
Total notes payable	700,000	700,000
Note Payable - Certus [Member]
Total notes payable	986,449	1,059,473
Note Payable - Debt Restructure Zicman [Member]
Total notes payable	$ 171,000	$ 171,000

Notes Payable, Related Partie_4

Notes Payable, Related Parties - Schedule of Future Maturities of Notes Payable, Related Parties (Details) - Notes Payable, Related Parties [Member]	Mar. 31, 2019USD ($)
2019	$ 1,674,400
2020	757,549
2021	426,000
2022	426,000
Thereafter	308,500
Total	$ 3,592,449

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Feb. 19, 2019	Jan. 10, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Oct. 31, 2018	Dec. 30, 2017	Nov. 17, 2014
Dividend paid			$ 524,806		$ 478,299
Exercise of stock option shares granted				6,800,000
Common stock, par value			$ 0.001		$ 0.001
Stock issued during the period				$ 119,000
Options exercise price per share
Common stock, shares outstanding			71,426,401		71,931,693
Common stock, shares authorized			200,000,000		200,000,000
Stock compensation expense			$ 322,954	$ 685,156
Employee Stock Purchase Program [Member]
Stock issued during the period, shares	457	623	707
Stock issued during the period	$ 233	$ 324	$ 252
2014 Stock Option Plan [Member]
Exercise of stock option shares granted			10,000,000
Maximum number of common shares reserved for issuance								10,000,000
Common stock shares subscribed			20,121,000
Warrants and Stock Options [Member]
Common stock, par value						$ 0.001
Minimum [Member] | Warrants and Stock Options [Member]
Common stock, shares authorized						10,000,000
Maximum [Member] | Warrants and Stock Options [Member]
Common stock, shares authorized						16,000,000
Settlement Agreement [Member]
Dividend rate per annum							$ 0.06
Debt settlement effective shares issued							1,685,000
Dividend paid
Board of Directors [Member]
Preferred stock voting rights			The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 250 common shares.
Series A Preferred Stock [Member]
Preferred stock shares designated			1,000,000		1,000,000
Preferred stock shares outstanding			0		0
Series B Preferred Stock [Member]
Preferred stock shares designated			1		1
Preferred stock shares outstanding			0		0
Series C Preferred Stock [Member]
Preferred stock shares designated			15,000,000		15,000,000
Preferred stock shares outstanding			4,828,530		4,828,530
Dividend rate per annum			$ 0.06
Preferred stock convertible description			Each Series C preferred share outstanding is convertible into one (1) share of common stock of Quest Solution, Inc.
Stock issued during the period, shares
Stock issued during the period

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Stock Options Warrants (Details) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Number of warrants balance, beginning of period	5,500,000	5,905,000
Number of warrants, granted
Number of warrants, expired		(300,000)
Number of warrants, cancelled, forfeited
Number of warrants, exercised
Number of warrants, balance end of period	5,500,000	5,605,000
Number of warrants, exercisable	5,500,000	4,885,000
Weighted Average Exercise Price balance, beginning of period	$ 0.23	$ 0.21
Weighted Average Exercise Price, granted
Weighted Average Exercise Price, expired		1
Weighted Average Exercise Price, cancelled, forfeited
Weighted Average Exercise Price, exercised
Weighted Average Exercise Price balance, end of period	0.23	0.21
Weighted Average Exercise Price, exercisable	$ 0.23	$ 0.23

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Outstanding Warrants (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Range of Exercise Prices, Upper Range Limit	$ 0.11
Range of Exercise Prices, Lower Range Limit	$ 0.60
Weighted Average residual life span (in years)	1 year 11 months 1 day
Outstanding Warrants | shares	5,500,000
Weighted Average Exercise Price	$ 0.23
Exercisable Warrants | shares	5,500,000
Weighted Average Exercise Price	$ 0.23
Exercise Price Range 1 [Member]
Range of Exercise Prices, Upper Range Limit	$ 0.11
Weighted Average residual life span (in years)	2 years 4 months 2 days
Outstanding Warrants | shares	1,500,000
Weighted Average Exercise Price	$ 0.11
Exercisable Warrants | shares	1,500,000
Weighted Average Exercise Price	$ 0.11
Exercise Price Range 2 [Member]
Range of Exercise Prices, Upper Range Limit	$ 0.20
Weighted Average residual life span (in years)	1 year 11 months 1 day
Outstanding Warrants | shares	3,000,000
Weighted Average Exercise Price	$ 0.20
Exercisable Warrants | shares	3,000,000
Weighted Average Exercise Price	$ 0.20
Exercise Price Range 3 [Member]
Range of Exercise Prices, Upper Range Limit	$ 0.28
Weighted Average residual life span (in years)	1 year 2 months 30 days
Outstanding Warrants | shares	200,000
Weighted Average Exercise Price	$ 0.28
Exercisable Warrants | shares	200,000
Weighted Average Exercise Price	$ 0.28
Exercise Price Range 4 [Member]
Range of Exercise Prices, Upper Range Limit	$ 0.50
Weighted Average residual life span (in years)	2 years 6 months
Outstanding Warrants | shares	500,000
Weighted Average Exercise Price	$ 0.50
Exercisable Warrants | shares	500,000
Weighted Average Exercise Price	$ 0.50
Exercise Price Range 5 [Member]
Range of Exercise Prices, Upper Range Limit	$ 0.60
Weighted Average residual life span (in years)	1 year 6 months 3 days
Outstanding Warrants | shares	300,000
Weighted Average Exercise Price	$ 0.60
Exercisable Warrants | shares	300,000
Weighted Average Exercise Price	$ 0.60

Stockholders' Equity - Schedu_3

Stockholders' Equity - Schedule of Warrants Outstanding, Expiry Date and Exercise Prices (Details) - $ / shares	Mar. 31, 2019	Mar. 31, 2018
Warrant outstanding	5,500,000	4,500,000
October 10, 2020 [Member]
Warrant expiry Date	Oct. 10, 2020	Oct. 10, 2020
Warrant exercise Prices	$ 0.60	$ 0.60
Warrant outstanding	300,000
December 30, 2020 [Member]
Warrant expiry Date	Dec. 30, 2020	Dec. 30, 2020
Warrant exercise Prices	$ 0.20	$ 0.20
Warrant outstanding	3,000,000	3,000,000
June 26, 2020 [Member]
Warrant expiry Date	Jun. 26, 2020	Jun. 26, 2020
Warrant exercise Prices	$ 0.28	$ 0.28
Warrant outstanding	200,000
August 2, 2021 [Member]
Warrant expiry Date	Aug. 2, 2021	Aug. 2, 2021
Warrant exercise Prices	$ 0.11	$ 0.11
Warrant outstanding	1,500,000	1,500,000
October 10, 2021 [Member]
Warrant expiry Date	Oct. 10, 2021	Oct. 10, 2021
Warrant exercise Prices	$ 0.50	$ 0.50
Warrant outstanding	500,000

Stockholders' Equity - Schedu_4

Stockholders' Equity - Schedule of Stock Options Granted (Details) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Number of stock options balance, beginning of period	20,121,000	9,625,000
Number of stock options, granted		6,800,000
Number of stock options, expired		72,000
Number of stock options, cancelled, forfeited
Number of stock options, exercised
Number of stock options balance, end of period	20,121,000	16,353,000
Number of stock options, exercisable	15,841,000	10,167,666
Weighted average exercise price balance, beginning of period	$ 0.24	$ 0.21
Weighted average exercise price, stock options granted		0.12
Weighted average exercise price, stock options expired		0.37
Weighted average exercise price, stock options cancelled, forfeited
Weighted average exercise price, stock options exercised
Weighted average exercise price balance, end of period	0.24	0.17
Weighted average exercise price, exercisable	$ 0.24	$ 0.20

Stockholders' Equity - Schedu_5

Stockholders' Equity - Schedule of Outstanding Stock Options (Details) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Range of Exercise Prices, Lower Range Limit	$ 0.075
Range of Exercise Prices, Upper Range Limit	$ 0.50
Weighted Average residual life span (in years)	3 years 4 months 9 days
Outstanding Stock Options | shares	20,121,000
Weighted Average Exercise Price	$ 0.24
Exercisable Stock Options | shares	15,841,000
Weighted Average Exercise Price	$ 0.24
Exercise Price Range 1 [Member]
Range of Exercise Prices, Lower Range Limit	0.075
Range of Exercise Prices, Upper Range Limit	$ 0.09
Weighted Average residual life span (in years)	2 years 10 months 17 days
Outstanding Stock Options | shares	2,281,000
Weighted Average Exercise Price	$ 0.09
Exercisable Stock Options | shares	2,281,000
Weighted Average Exercise Price	$ 0.08
Exercise Price Range 2 [Member]
Range of Exercise Prices, Lower Range Limit	$ 0.11
Weighted Average residual life span (in years)	2 years 4 months 2 days
Outstanding Stock Options | shares	3,500,000
Weighted Average Exercise Price	$ 0.11
Exercisable Stock Options | shares	3,500,000
Weighted Average Exercise Price	$ 0.11
Exercise Price Range 3 [Member]
Range of Exercise Prices, Lower Range Limit	$ 0.12
Weighted Average residual life span (in years)	3 years 11 months 4 days
Outstanding Stock Options | shares	6,800,000
Weighted Average Exercise Price	$ 0.12
Exercisable Stock Options | shares	5,950,000
Weighted Average Exercise Price	$ 0.12
Exercise Price Range 4 [Member]
Range of Exercise Prices, Lower Range Limit	$ 0.22
Weighted Average residual life span (in years)	4 years 7 months 2 days
Outstanding Stock Options | shares	2,165,000
Weighted Average Exercise Price	$ 0.22
Exercisable Stock Options | shares	541,250
Weighted Average Exercise Price	$ 0.22
Exercise Price Range 5 [Member]
Range of Exercise Prices, Lower Range Limit	$ 0.27
Weighted Average residual life span (in years)	4 years 8 months 2 days
Outstanding Stock Options | shares	2,875,000
Weighted Average Exercise Price	$ 0.27
Exercisable Stock Options | shares	1,068,750
Weighted Average Exercise Price	$ 0.27
Exercise Price Range 6 [Member]
Range of Exercise Prices, Lower Range Limit	$ 0.50
Weighted Average residual life span (in years)	5 years 7 months 21 days
Outstanding Stock Options | shares	2,500,000
Weighted Average Exercise Price	$ 0.50
Exercisable Stock Options | shares	2,500,000
Weighted Average Exercise Price	$ 0.50

Stockholders' Equity - Schedu_6

Stockholders' Equity - Schedule of Stock Options, Expiry Date and Exercise Prices (Details) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Stock option exercise prices	$ 0.24	$ 0.17	$ 0.24	$ 0.21
Stock option outstanding	20,121,000	16,353,000	20,121,000	9,625,000
August 2, 2021 [Member]
Stock option expiration date	Aug. 2, 2021	Aug. 2, 2021
Stock option exercise prices	$ 0.11	$ 0.11
Stock option outstanding	3,500,000	3,500,000
February 17, 2022 [Member]
Stock option expiration date	Feb. 17, 2022	Feb. 17, 2022
Stock option exercise prices	$ 0.075	$ 0.075
Stock option outstanding	760,333	760,333
February 17, 2022 [Member]
Stock option expiration date	Feb. 17, 2022	Feb. 17, 2022
Stock option exercise prices	$ 0.09	$ 0.09
Stock option outstanding	1,520,667	1,520,667
March 5, 2023 [Member]
Stock option expiration date	Mar. 5, 2023	Mar. 5, 2023
Stock option exercise prices	$ 0.12	$ 0.12
Stock option outstanding	6,800,000	6,800,000
October 31, 2023 [Member]
Stock option expiration date	Oct. 31, 2023	Oct. 31, 2023
Stock option exercise prices	$ 0.22	$ 0.22
Stock option outstanding	2,165,000
November 30, 2023 [Member]
Stock option expiration date	Nov. 30, 2023	Nov. 30, 2023
Stock option exercise prices	$ 0.27	$ 0.27
Stock option outstanding	2,875,000
November 20, 2024 [Member]
Stock option expiration date	Nov. 20, 2024	Nov. 20, 2024
Stock option exercise prices	$ 0.25	$ 0.25
Stock option outstanding	2,500,000

Leases (Details Narrative)

Leases (Details Narrative) - USD ($)	Mar. 31, 2019	Jan. 02, 2019	Dec. 31, 2018
Weighted average remaining lease terms	2 years 8 months 12 days
Weighted average remaining discount rates	14.60%
Right-of-use assets	$ 214,611	$ 237,731
Lease liabilities	219,507	$ 237,731
Lease liabilities, noncurrent	$ 121,405
Minimum [Member]
Incremental borrowing rate	13.16%
Maximum [Member]
Incremental borrowing rate	15.06%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Commitments (Details) - USD ($)	Mar. 31, 2019	Jan. 02, 2019	Dec. 31, 2018
Unamortized Share-based Compensation
2019 (excluding the three months ended March 31, 2019)	$ 94,971
2020	81,919
2021	36,365
2022 and thereafter	53,200
Total lease payments	266,456
Less imputed interest	(46,949)
Total	$ 219,507	$ 237,731

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information (Details)	3 Months Ended
	Mar. 31, 2019USD ($)
Unamortized Share-based Compensation
Cash flows from operating activities - operating leases	$ 19,916
Right-of-use assets obtained in exchange for lease obligations: Operating leases	$ 17,066

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	May 29, 2019	Apr. 04, 2019	Oct. 05, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Aggregate gross proceeds from issuance of stock				$ 1,000
Common stock, par value				$ 0.001		$ 0.001
Campbeltown Consulting, Inc [Member]
Converted principal amount			$ 150,000
Walefar Investments, Ltd [Member]
Converted principal amount			$ 150,000
Subsequent Event [Member] | HTS Purchase Agreement [Member] | Minimum [Member]
Shares issued in acquisition	11,368,297
Shares issued in acquisition, consideration	$ 2,682,918
Subsequent Event [Member] | HTS Purchase Agreement [Member] | Maximum [Member]
Shares issued in acquisition	22,452,954
Shares issued in acquisition, consideration	$ 5,298,897
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Aggregate to sold included conversions		$ 5,000,000
Aggregate gross proceeds from issuance of stock		$ 5,000,000
Purchase price per share unit		$ 0.30
Debt dsecription		Each Unit is comprised of one share of the Company's common stock, $0.001 par value per share (the "Common Stock"), and a warrant to purchase one share of Common Stock, and, as a result of the Offering, the Company issued 16,666,667 shares of Common Stock (the "Shares") and warrants (the "Warrants") to purchase 16,666,667 shares of Common Stock (the "Warrant Shares") at an exercise price equal to $0.35 per Warrant Share, which Warrants are exercisable for a period of five and one-half years from the issuance date. Both Shai Lustgarten, the Company's Chief Executive Officer, and Carlos J. Nissensohn, a consultant to and principal stockholder of the Company, participated in the Offering by converting $200,000 each of unpaid principal owed to them from the HTS acquisition (the "Conversions") by the Company in exchange for Shares and Warrants on the same terms as all other Purchasers.
Common stock, par value		$ 0.001
Number of shares issued for common stock		16,666,667
Warrant purchase of common stock		16,666,667
Warrant exercise price per share		$ 0.35
Converted principal amount		$ 200,000
Gross proceeds from offering		5,000,000
Subsequent Event [Member] | Campbeltown Consulting, Inc [Member]
Number of shares return fo cancellation	5,542,328
Converted principal amount		150,000
Subsequent Event [Member] | Walefar Investments, Ltd [Member]
Number of shares return fo cancellation	5,542,329
Converted principal amount		$ 150,000